Registry for patients treated with ALTO endograft for abdominal aortic aneurysm
Official title: ALTo endogrAft Italian Registry
Run by Azienda Ospedaliera Universitaria Senese · NCT05234892 · Data updated 2026-11-12
This study looks at how well the ALTO stent graft works for people having surgery to fix abdominal aortic aneurysms and what outcomes they experience afterward.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Azienda Ospedaliera Universitaria Senese Academic / other |
| Locations | 2 sites (Rome and 1 other locations) |
| Status | Recruiting |
| Started | January 1, 2022 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2028 |
| Registry record updated | July 20, 2023 |
| Trial ID | NCT05234892 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old who are scheduled for elective endovascular aneurysm repair using the ALTO endograft.
✕Probably not a fit
Patients requiring urgent or emergent repair of AAA or those with contraindications to the ALTO endograft will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate the intraoperative, peri-operative, and post-operative outcomes of patients undergoing elective repair of abdominal aortic aneurysms (AAA) using the ALTO stent graft. The study will collect data from multiple centers to assess the effectiveness and safety of this innovative endograft device. By analyzing the results from a diverse patient population, the study seeks to provide insights into the performance of the ALTO endograft in various anatomical challenges. The research will focus on long-term outcomes and complications associated with the use of this device.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of the ALTO endograft's effectiveness, potentially leading to improved treatment options for patients with AAA.
How similar studies have gone: While there have been studies on endovascular aneurysm repair, this specific evaluation of the ALTO endograft is relatively novel and has limited published outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Elective AAA patients that should be treated by standard EVAR, according to Endologix Alto endograft device's Instructions For Use; * Patient is willing to comply with specified follow-up evaluations at the specified times for the duration of the study; * Patient is \>18 years old; * Patient, or their legal representative, understands the nature of the procedure and provides written informed consent, prior to enrollment in the study. Exclusion Criteria: * EVAR performed in Urgent/Emergent setting; * Patients treated outside Endologix Alto endograft device's Instructions For Use; * Patients refusing treatment; * Patients for whom antiplatelet therapy, anticoagulants or antihypertensive drug are contraindicated; * Patients with a history of prior life-threatening contrast medium reaction; * Life expectancy of less than follow-up period. AAA: abdominal aortic aneurysm; EVAR: abdominal endovascular aneurysm
Where it's running
-
University La Sapienza of Rome
Rome, Italy Recruiting -
University of Siena
Siena, Italy Recruiting
Study contacts
- Principal investigator: Gianmarco de Donato, MD, PhD — University of Siena
- Study coordinator: Gianmarco de Donato, MD, PhD
- Email: dedonato@unisi.it
- Phone: +390577585123
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cardiovascular Rehabilitation After Abdominal Aortic Aneurysm Repair
This study tests whether a structured cardiovascular rehabilitation program after abdominal aortic aneurysm repair leads to better fitness and quality of life than standard postoperative care.
-
Imaging inflammation in abdominal aortic aneurysm using a PET tracer
Researchers are testing whether a new PET tracer, 64Cu-DOTA-ECL1i, can image inflammation in an abdominal aortic aneurysm.
-
Poland–Italy Aortic Bridge Registry: PERCUTEK Tycheseal for Abdominal Aortic Aneurysm
This registry will see how well the PERCUTEK Tycheseal stent-graft works and how safe it is for adults having endovascular repair of abdominal aortic aneurysms.
-
PET scan to image MMP activity in abdominal aortic aneurysm
We will test whether a new PET tracer ([64Cu]-RYM2) can safely image MMP activity in people with abdominal aortic aneurysm and in healthy volunteers.
-
CTA registry for abdominal aortic aneurysm measurements
This registry will collect CT angiography scans from people with abdominal aortic aneurysms to see if CTA measurements reliably describe aneurysm size and features.
-
Cygnum aneurysm sac lining used with EVAR for abdominal aortic aneurysm
This trial will test whether adding the Cygnum sac lining to standard EVAR is safe and helps prevent type II endoleaks in people with abdominal aortic aneurysms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.